Zalevsky Jonathan

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)2%< 1%< 1%0%
Sale Success Rate2 of 92 of 92 of 91 of 90 of 9

Nektar Therapeutics

Drugs » Drug Delivery

Chief R&D Officer:

Holdings: 243.02K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--